Table 3.
Summary of potassium binder usage in patients with any HK event.
Potassium binder usage | n = 453 |
---|---|
Total number of HK events | 2065 |
Treated with potassium binders, n (% [95%CI]) | 54 (2.62 [1.93–3.3]) |
SPS | 17 (0.82 [0.43–1.21]) |
CPS | 28 (1.36 [0.86–1.85]) |
SZC | 13 (0.63 [0.29–0.97]) |
Total number of patients with HK | 453 |
Treated with potassium binders, n (% [95% CI]) | 24 (5.30 [3.24–7.36]) |
SPS | 7 (1.55 [0.41–2.68]) |
CPS | 13 (2.87 [1.33–4.41]) |
SZC | 6 (1.32 [0.27–2.38]) |
CI, confidence interval; CPS, calcium polystyrene sulfonate; HK, hyperkalemia; SD, standard deviation; SPS, sodium polystyrene sulfonate; SZC, sodium zirconium cyclosilicate.